Marked hypertriglyceridemia with a novel splicing mutation in GPIHBP1
Pediatrics International · 2023
DOI: 10.1111/ped.15559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, 2023. Verfasst von Sakura Kawahara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Hyperlipidemias, Receptors, Lipoprotein. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
- Department of Child Health, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
ORCID-Profile: Kazuo Imagawa, Hisato Suzuki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kawahara, S., Imagawa, K., Suzuki, H., Ohto, T., & Takada, H. (2023). Marked hypertriglyceridemia with a novel splicing mutation in GPIHBP1. Pediatrics International. https://doi.org/10.1111/ped.15559
Vancouver
Kawahara S, Imagawa K, Suzuki H, Ohto T, Takada H. Marked hypertriglyceridemia with a novel splicing mutation in GPIHBP1. Pediatrics International. 2023. doi:10.1111/ped.15559
BibTeX
@article{Kawahara2023,
author = {Kawahara, Sakura and Imagawa, Kazuo and Suzuki, Hisato and Ohto, Tatsuyuki and Takada, Hidetoshi},
title = {Marked hypertriglyceridemia with a novel splicing mutation in GPIHBP1},
journal = {Pediatrics International},
year = {2023},
doi = {10.1111/ped.15559}
}
EUVIMED